Comparative effects of adenosine-5'-triphosphate and related analogues on insulin secretion from the rat pancreas

Fundamental and Clinical Pharmacology

Volumn 11, Issue 6, 1997, Pages 537-545

  Chapal, J ^a   Hillaire Buys, D ^a   Bertrand, G ^a,b   Pujalte, D ^a   Petit, P ^a   Loubatieres Mariani M M ^a  

^a Laboratoire de Biochimie Genetique   (France)

^b UPR 9023 du CNRS   (France)

Author keywords

Adenine nucleotides; B cells; P2 purinoceptors

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; PURINE P2 RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

EID: 0030702921     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1997.tb00858.x     Document Type: Article

References (53)

1. Babkina GT, Zarytova VF, Knorre DG. Preparation of γ-amides of nucleotide 5′-triphosphates in aqueous solution with water soluble carbodiimide. Bioorg Khim 1975;1:611-5
2. 2-purinoceptors on β cell and pancreatic vascular bed. Br J Pharmacol 1987;91:783-7
3. Bertrand G, Gross R, Chapal J, Loubatières-Mariani MM. Difference in the potentiating effect of adenosine triphosphate and α,β-methylene ATP on the biphasic insulin response to glucose. Br J Pharmacol 1989;98:998-1004
4. 2-purinoceptors mediating insulin secretion from perfused rat pancreas. Br J Pharmacol 1991;102:627-30
5. Brown C, Burnstock G, Cocks T. Effects of adenosine-5′-triphosphate (ATP) and β,γ-methylene ATP on the rat urinary bladder. Br J Pharmacol 1979;65:97-102
6. Burnstock G. A basis for distinguishing two types of purinergic receptor. In: Straub RW, Bolis L, eds. Cell Membrane Receptors for Drug and Hormones: A Multidisciplinary Approach. New York: Raven Press, 1978;107
7. 2-purinoceptor agonist. Br J Pharmacol 1985;84:825-31
8. 2 purinoceptors? Gen Pharmacol 1985;16:433-40
9. 2x-purinoceptor. Br J Pharmacol 1987;90:383-91
10. 2-purinoceptor. Br J Pharmacol 1983;79:907-13
11. Burnstock G, Cusack NJ, Meldrum LA. Effects of phosphorothioate analogues of ATP, ADP and AMP on guinea-pig taenia coli and urinary bladder. Br J Pharmacol 1984;82: 369-74
12. 2-puricoceptor on the guinea-pig vas deferens. Br J Pharmacol 1985;84:431-4
13. 2Y subtypes. Drug Dev Res 1994;31:206-19
14. Chapal J, Loubatières-Mariani MM. Effects of phosphate-modified adenine nucleotide analogues on insulin secretion from perfused rat pancreas. Br J Pharmacol 1981;73: 105-10
15. u dependent reactions. Biochemistry 1977;16:4312-9
16. 2 receptor: subclassification and structure-activity relationships. Drug Dev Res 1993;28:244-52
17. Cusack NJ, Planker M. Relaxation of isolated taenia coli of guinea-pig by enantiomers of 2-azido analogues of adenosine and adenine nucleotides. Br J Pharmacol 1979;67:153-8
18. Cusack NJ, Hourani SM. Some pharmacological and biochemical interactions of the enantiomers of adenyl 5′-(β,γ-methylene)-diphosphonate with the guinea-pig urinary bladder. Br J Pharmacol 1984;82:155-9
19. 2-purinoceptors in guinea-pig taenia coli and urinary bladder. Br J Pharmacol 1987;90:791-5
20. Fedan JS, Hogaboom GK, Westfall DP, O'Donnell JP. Comparison of contractions of the smooth muscle of the guinea-pig vas deferens induced by ATP and related nucleotides. Eur J Pharmacol 1982;81:193-204
21. Fedan JS, Hogaboom GK, O'Donnell JP. Further comparison of contractions of the smooth muscle of the guinea-pig isolated vas deferens induced by ATP and related analogs. Eur J Pharmacol 1986;129:279-91
22. 2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5′-triphosphate. J Med Chem 1993;36:3937-46
23. Fredholm BB, Abbracchio MP, Burnslock G, Daly JW, Harden TK, Jacobson KA et al. Nomenclature and classification of purinoceptors. Pharmacol Rev 1994;46:143-56
24. Gordon JL. Extracellular ATP: effects, sources and fate. Biochem J 1986;233:309-19
25. 2-purinergic receptors: subtype-associated signaling responses and structure. Annu Rev Pharmacol Toxicol 1995;35:541-79
26. Herbert V, Law KS, Gottlieb CW, Bleicher SJ. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 1965;25: 1375-84
27. 1 subtype adenosine receptor on pancreatic insulin-secreting cells. Eur J Pharmacol 1987;136:109-12
28. 2Y purinoceptor responses of βcells and vascular bed are preserved in diabetic rat pancreas. Br J Pharmacol 1992;106:610-5
29. Hiratsuka T, Uchida K. Preparation and properties of 2′(or 3′)-0-(2,4,6-trinitrophenyl) adenosine 5′-triphosphate, an analog of adenosine triphosphate. Biochem Biophys Acta 1973; 320:635-47
30. Hourani SM, Loizou GD, Cusack NJ. Pharmacological effects of L-AMP-PCP on ATP receptors in smooth muscle. Eur J Pharmacol 1986;131:99-103
31. 2X-receptors (on the guinea-pig bladder). Eur J Med Chem 1988;23:433-9
32. Jeng SJ, Guillory RJ. The use of arylazido ATP analogs as photoaffinity labels for myosin ATPase. J Supramolec Struct 1975;3:448-68
33. 2-purinoceptor: effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder. Eur J Pharmacol 1983;86:291-4
34. Loubatières AL, Mariani MM, De Malbosc H, Ribes G, Chapal J. Etude expérimentale d'un nouveau sulfamide hypoglycémiant particulièrement actif, le HB 419 ou glibenclamide. I. Action bêtacytotrope et insulino-sécrétrice. Diabetologia 1969;5:1-10
35. Loubatières-Mariani MM, Loubatières AL, Chapal J, Valette G. Adénosine triphosphate (ATP) et glucose. Action sur les sécrétions d'insuline et de glucagon. C R Soc Biol 1976; 170:833-6
36. Loubatières-Mariani MM, Chapal J, Lignon F, Valette G. Structural specificity of nucleotides for insulin secretory action from the isolated perfused rat pancreas. Eur J Pharmacol 1979;59:277-86
37. Lukacsko P, Kreill RD. Response of the guinea-pig urinary bladder to purine and pyrimidine nucleotides. Eur J Pharmaocol 1982;80:401-6
38. 5 A and α,β-methylene ATP on nonadrenergic, noncholinergic neurogenic excitation in the guinea-pig vas deferens. Br J Pharmacol 1988;94: 699-706
39. Maguire MH, Satchell DG. The contribution of adenosine to the inhibitory actions of adenine nucleotides on the guinea-pig taenia coli: studies with phosphate-modified adenine nucleotide analogs and dipyridamole. J Pharmacol Exp Ther 1979;211:626-31
40. 2-purinergic receptors of isolated guinea-pig vas deferens by arylazido aminopropionyl ATP and by arylazido aminobutyryl ATP. Eur J Pharmacol 1983;86:435-40
41. Olsson RA, Pearson JD. Cardiovascular purinoceptors. Physiol Rev 1990;70:761-845
42. Petit P, Bertrand G, Schmeer W, Henquin JC. Effects of extracellular adenine nucleotides on the electrical, ionic and secretory events in mouse pancreatic β-cells. Br J Pharmacol 1989;98:875-82
43. 2-purinoceptor subtypes in the isolated perfused mesenteric bed of the rat. Br J Pharmacol 1988;95:637-45
44. Rosendahl MS, Leonard NJ. β,γ-Peroxy analogs of adenosine and guanosine triphosphate: synthesis and biological activity. Science 1982;215:81-2
45. Satchell DG, Maguire MH. Inhibitory effects of adenine nucleotide analogs on the isolated guinea-pig taenia coli. J Pharmacol Exp Ther 1975;195:540-8
46. Satchell DG, Maguire MH. Evidence for separate receptors for ATP and adenosine in the guinea-pig taenia coli. Eur J Pharmacol 1982;81:669-72
47. 2 purinoceptor agonists in Zucker diabetic fatty rats. Am J Physiol 1996;270: E504-12
48. 2Y purinoceptors. Biochem Biophys Res Commun 1995;211:211-8
49. Vandest P, Labbe JP, Kassab R. Photoaffinity labelling of arginine kinase and creatinine kinase with γ-p-substitued arylazido analogue of ATP. Eur J Biochem 1980;104:433-42
50. 2X receptor subtype widely expressed in brain and peripheral tissues including various endocrine tissues. Biochem Biophys Res Commun 1996;220:196-202
51. Watson S, Girdlestone D. Receptor and ion channel nomenclature (7th edn). Trends Pharmacol Sci 1996;58
52. 2X-purinoceptors: evidence that dephosphorylation of ATP analogues reduces pharmacological potency. Eur J Pharmacol 1987;141:123-30
53. Zar JH. Biostatistical Analysis. Englewood Cliffs, NJ: Prentice-Hall, 1974;151